Quality records for ISO IEC 17025 accreditation, GLP documentation, and calibration review at ARE Labs
ARE Labs

Quality documentation connects ISO/IEC 17025 accreditation, GLP documentation options, and calibration records to the scope of a study.

Quality

EPA GLP Inspection & ISO/IEC 17025 Quality

ARE Labs completed its first on-site U.S. EPA FIFRA GLP inspection and selected study audit in August 2026. That independent regulatory oversight complements an ISO/IEC 17025-accredited testing scope and documented controls for protocols, instruments, calibration, records, and reporting.

ARE Labs completed a U.S. EPA FIFRA GLP inspection in August 2026 and maintains ISO/IEC 17025 accreditation for its current testing scope.

U.S. EPA FIFRA GLP inspected · Aug 2026ISO/IEC 17025-accredited testing scopeDEA Schedule I analytical & researchKS Board of Pharmacy analytical & researcherGLP study controls under 40 CFR Part 160
Credentials at a glance

Accreditations, licenses, and quality documentation

These ARE-owned marks summarize the accreditations, authorizations, inspection history, and documented quality controls described on this page. They are not official ISO, DEA, Kansas Board, or EPA marks. Select a credential to review its scope and supporting documentation.

Inspected · August 2026

EPA FIFRA GLP inspection

ARE Labs completed an on-site U.S. EPA FIFRA GLP facility inspection and selected study audit under 40 CFR Part 160.

Analytical and researcher

Kansas Board of Pharmacy

Kansas licensing supports eligible analytical and research activities; applicability is confirmed against current license documentation.

Instrument controls

Calibration traceability

Measurement claims stay tied to named instruments, calibration records, service status, and study conditions.

Reviewable study records

Quality records

Protocols, chain-of-custody where applicable, deviations, raw data, and report review are kept inside the study record.

Accreditation

ISO/IEC 17025 accredited testing scope

ARE Labs maintains ISO/IEC 17025 accreditation for its current scope of testing. The accreditation addresses laboratory competence and the quality-system controls used for activities listed in the current certificate and scope.

Certificate details, scope coverage, and method status should be checked against the current certificate and scope. Methods outside that scope are described as standards-aligned or custom protocol work.

Federal authorization

DEA Schedule I analytical and research authorization

ARE Labs maintains DEA Schedule I analytical and research authorization for its current registered scope. Before a study is accepted, the applicable substance schedule, protocol, storage, handling, and documentation requirements are confirmed against current authorization records.

ARE Labs quality recordU.S. EPAFIFRA GLPInspection completed
Independent regulatory oversight

EPA scrutiny of the systems behind the data.

ARE Labs completed its first on-site U.S. EPA FIFRA GLP facility inspection and selected study audit under 40 CFR Part 160 in August 2026.

Authority
U.S. Environmental Protection Agency
Inspection dates
Regulatory framework
40 CFR Part 160
Scope reviewed
Facility quality systems · Selected GLP study records · Documentation and data controls

Final written agency report pending. This record describes a regulatory inspection; it does not imply EPA certification or endorsement.

State authorization

Kansas Board of Pharmacy analytical and researcher licensing

Kansas Board of Pharmacy licensing supports eligible analytical and research activities conducted by ARE Labs in Kansas. Project-specific applicability is confirmed against current license documentation before work involving controlled substances is scoped.

Measurement control

Calibration traceability tied to study instruments

Reported measurements are connected to identified instruments, calibration and service records, equipment status, and the conditions documented for the study. Traceability statements remain bounded by the records and instruments used for that work.

Study documentation

Reviewable quality and study records

The study record can include the approved protocol, raw data, instrument records, chain-of-custody where applicable, deviations, quality assurance review, and report review. The documentation retained for a project follows its agreed scope and applicable quality requirements.

Controlled-substance licensing

DEA and Kansas controlled-substance authorizations

No.AuthorityLicense / registrationPublic boundary
01U.S. Drug Enforcement AdministrationDEA Schedule I analytical and research license / registration for the current authorized scope.Current authorization, substance schedules, storage, handling, and protocol limits are verified through current documentation before a study is scoped.
02Kansas Board of PharmacyKansas Board of Pharmacy analytical and researcher license / registration for the current authorized scope.State licensing supports eligible analytical and research activities in Kansas; project-specific applicability is confirmed against current license documentation.
Documentation controls

Controls that can be described conservatively

No.ControlWhat it supportsPublic boundary
01Standard operating procedures (SOPs)Define how recurring tasks, instruments, and study steps are performed and recorded.SOPs support repeatable practice and the accredited quality system; they do not make every custom study externally accredited.
02Documented protocolsDefine study scope, setup, measurements, controls, and reportable outputs.Claims are tied to the documented protocol and agreed study scope.
03Instrument recordsConnect reported measurements to named instruments and study conditions.Measurement statements stay tied to the instruments and conditions used in the study.
04Calibration traceabilitySupports confidence in instruments and measurement records.Traceability statements are tied to available calibration and instrument records.
05Chain-of-custodyTracks sample handling and identity through the study where applicable.Applied where sample handling and identity matter to the study question.
06Deviations and technical reviewSupport raw-data review, deviation handling, and reporting discipline within the study.GLP controls under 40 CFR Part 160 are applied to applicable FIFRA studies; other studies use the controls defined in their protocols.
Good Laboratory Practice

GLP study controls under 40 CFR Part 160

For applicable FIFRA studies, ARE Labs applies GLP controls under 40 CFR Part 160: protocol control, raw-data capture and review, instrument and calibration records, deviation handling, quality assurance review, and a reviewable study record from setup through final report.

For other studies, the same documentation disciplines can be scoped when they improve clarity and defensibility. GLP is a regulatory study framework rather than a product certification, and the applicable requirements are defined for each study.

Accreditation scope

Request current certificate and scope

For documentation questions, ask for the current ISO/IEC 17025 certificate, DEA Schedule I analytical/research authorization, Kansas Board of Pharmacy analytical/researcher license documentation, or records that apply to a specific study or protocol.